In this study we investigated the involvement of PTTG1 in the regulation of proliferation and invasiveness of melanoma cells sensitive or resistant to dabrafenib and whether targeting PTTG1 could affect the response of those cells to the BRAFi. This evidence concerns the gene PTTG1 and melanoma.